Uncover how innovative screening strategies and immune profiling are reshaping donor selection in cell therapy. In this on-demand session from Phacilitate, developed in collaboration with Excellos™, industry experts explore how a deeper understanding of donor characteristics can lead to more effective and consistent therapeutic outcomes.

This webinar dives into the limitations of traditional starting material selection and how data analytics, metabolic assessments, and machine learning are empowering developers to make smarter, more holistic choices from the outset.

Key highlights include:
✔ Identifying optimal starting materials to align with clinical delivery strategies
✔ Improving cell potency through immune profiling and functional assessments
✔ Reducing clinical variability by refining donor selection processes
✔ Leveraging machine learning to guide end-to-end donor screening

Watch now to discover how a data-driven approach to starting material can drive more predictable, effective, and safer cell therapies.

Brought to you in collaboration with Excellos™.

Disclaimer: This webinar is part of our legacy content, hosted on a previous platform. As a result, some interactive or engagement features may be limited.